VivoSim Labs, Inc..
VIVS.US | Research and experimental development on natural sciences and engineering
VivoSim Labs, Inc. is a biotechnology company focused on developing and commercializing advanced simulation and modeling technologies for the pharmaceutical and healthcare industries. Their primary offering is a software platform that allows researchers and drug developers to simulate biological pro...Show More
Better Health for All
20
VivoSim Labs' core business, the NAMkind™ platform, is entirely focused on delivering transformative health benefits by improving drug development. The NAMkind™ Intestine model demonstrates functionality for safer and more effective IBD therapies, exhibiting gene expression and phenotypic characteristics aligning with native human intestinal tissue and responsiveness to clinically used therapeutics.
1
The platform predicts liver toxicity with 87.5% sensitivity and 100% specificity, aiming to reduce clinical trial failures due to liver toxicity by 50% or more.
2
The company's technology replaces animal testing, aligning with the FDA's plan to phase out animal testing requirements in favor of new approach methodologies (NAM).
3
VivoSim's products do not have significant negative health impacts; instead, they are intended to reduce harmful outcomes in drug development. The company's operations do not generate significant health externalities, as its focus is on computational modeling and in vitro systems. The company does not conduct or sponsor clinical trials directly, but rather provides tools for drug developers.
Fair Money & Economic Opportunity
0
VivoSim Labs, Inc. is a biotechnology company focused on developing simulation and modeling technologies for the pharmaceutical and healthcare industries. Its core business involves software licensing, consulting, and custom model development for pharmaceutical companies, research institutions, and healthcare providers. The provided articles contain financial data related to the company's own performance and regulatory filings, but no evidence regarding its involvement in lending, deposit services, or any other financial products or services offered to consumers or businesses that would fall under the scope of 'Fair Money & Economic Opportunity'. Therefore, there is no specific, concrete data to score any of the KPIs for this value.
Fair Pay & Worker Respect
0
No evidence available to assess VivoSim Labs, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific data or relevant information regarding VivoSim Labs, Inc.'s (VIVS.US) performance on fair trade and ethical sourcing KPIs was found in the provided articles.
1
The articles primarily discuss general industry trends, financial information for VIVS.US, or explicitly state the absence of relevant data for the company.
2
Honest & Fair Business
-60
VivoSim Labs, Inc. has a whistleblower policy, last amended in May 2025, which includes procedures for anonymous and confidential reporting of violations.
1
However, there is no evidence of an independent investigation process or specific details on its effectiveness. The company also has an anti-corruption policy that addresses the Foreign Corrupt Practices Act and other anti-corruption statutes.
2
This policy is FCPA-compliant, but there is no information on the frequency or effectiveness of training. Furthermore, the company has less than 10% of its ethical claims independently verified, with only integrity screening and due diligence assessments mentioned for third parties.
Kind to Animals
0
No evidence available to assess VivoSim Labs, Inc. on Kind to Animals.
No War, No Weapons
0
VivoSim Labs, Inc. is a biotechnology company focused on pharmaceutical and healthcare simulation technologies
1
, with no evidence of involvement in arms manufacturing, military contracts, or dual-use technologies.
2
The company has a conflict minerals sourcing policy stating it does not directly purchase conflict minerals, but its products may contain them.
3
The policy emphasizes verifying that vendors and their suppliers do not source minerals from armed groups in the eastern Democratic Republic of Congo region.
4
No specific percentage of the supply chain certified conflict-free is provided, nor is there evidence of third-party verification or comprehensive traceability systems beyond the policy statement.
5
Planet-Friendly Business
0
No evidence available to assess VivoSim Labs, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess VivoSim Labs, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess VivoSim Labs, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
The provided articles do not contain any specific, concrete data points or information relevant to VivoSim Labs, Inc.'s performance regarding zero waste and sustainable products.
1
There is no mention of waste diversion rates, product recyclability, packaging sustainability, recycled content, waste reduction initiatives, or any other metrics related to this ethical value.
2